According to a report from Australian ProactiveInvestors.com, SomnoMed, Sydney, Australia, signed two independent agreements with home sleep diagnostics and patient treatment care companies Watermark Medical and SleepQuest in the United States and Canada. The alliances are geared toward bringing SomnoMed closer to the diagnostic process of sleep disordered breathing.
“Both companies, we believe, will play a significant role in the future of the sleep diagnostic industry in the US and Canada,” SomnoMed CEO Ralf Barschow said in the report. “We at SomnoMed feel very privileged to have been invited to work closely with these companies and to position our SomnoDent device as the preferred oral appliance.”
